Macquarie Initiates Coverage On Braze with Neutral Rating, Announces Price Target of $30
BRZEBraze Analysts Hail Its cRPO Momentum While Keeping Their Guard Over Macro Challenges
BRZE6 Analysts Have This to Say About Braze
BRZEAnalysts have provided the following ratings for Braze (NASDAQ:BRZE) within the last quarter:
Cowen & Co. Maintains Outperform on Braze, Lowers Price Target to $50
BRZEDow To $45? Here Are 5 Other Price Target Changes For Tuesday
BRZEJefferies cut the price target on Dow Inc. (NYSE: DOW) from $71 to $45. Jefferies analyst Laurence Alexander also downgraded the stock from Buy to Hold. Dow shares fell 0.8% to $50.55 in pre-market trading.
Raymond James Maintains Outperform on Braze, Raises Price Target to $50
BRZEOppenheimer Maintains Outperform on Braze, Raises Price Target to $48
BRZEPiper Sandler Maintains Overweight on Braze, Raises Price Target to $47
BRZE12 Information Technology Stocks Moving In Monday's After-Market Session
BRZEGainers
VirnetX Holding (NYSE:VHC) shares rose 8.3% to $1.43 during Monday's after-market session. The company's market cap stands at $102.1 million.
Braze Sees FY23 Revenue $347M-$350M Vs $346.83M Est
BRZEBraze Sees Q3 2023 Revenue $90M-$91M Vs $90.03M Est; Sees Q3 2023 Adj. EPS $(0.23)-$(0.22) Vs $(0.20) Est.
BRZEBraze Q2 EPS $(0.16) Beats $(0.20) Estimate, Sales $86.10M Beat $81.10M Estimate
BRZE